1. Home
  2. AAOI vs ALXO Comparison

AAOI vs ALXO Comparison

Compare AAOI & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAOI
  • ALXO
  • Stock Information
  • Founded
  • AAOI 1997
  • ALXO 2015
  • Country
  • AAOI United States
  • ALXO United States
  • Employees
  • AAOI N/A
  • ALXO N/A
  • Industry
  • AAOI Semiconductors
  • ALXO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AAOI Technology
  • ALXO Health Care
  • Exchange
  • AAOI Nasdaq
  • ALXO Nasdaq
  • Market Cap
  • AAOI 561.7M
  • ALXO 81.1M
  • IPO Year
  • AAOI 2013
  • ALXO 2020
  • Fundamental
  • Price
  • AAOI $19.00
  • ALXO $1.51
  • Analyst Decision
  • AAOI Buy
  • ALXO Strong Buy
  • Analyst Count
  • AAOI 3
  • ALXO 6
  • Target Price
  • AAOI $15.33
  • ALXO $14.20
  • AVG Volume (30 Days)
  • AAOI 2.6M
  • ALXO 518.7K
  • Earning Date
  • AAOI 11-07-2024
  • ALXO 11-11-2024
  • Dividend Yield
  • AAOI N/A
  • ALXO N/A
  • EPS Growth
  • AAOI N/A
  • ALXO N/A
  • EPS
  • AAOI N/A
  • ALXO N/A
  • Revenue
  • AAOI $206,944,000.00
  • ALXO N/A
  • Revenue This Year
  • AAOI $14.87
  • ALXO N/A
  • Revenue Next Year
  • AAOI $78.81
  • ALXO N/A
  • P/E Ratio
  • AAOI N/A
  • ALXO N/A
  • Revenue Growth
  • AAOI N/A
  • ALXO N/A
  • 52 Week Low
  • AAOI $6.66
  • ALXO $1.42
  • 52 Week High
  • AAOI $24.75
  • ALXO $17.83
  • Technical
  • Relative Strength Index (RSI)
  • AAOI 68.92
  • ALXO 30.69
  • Support Level
  • AAOI $16.93
  • ALXO $1.42
  • Resistance Level
  • AAOI $19.46
  • ALXO $1.62
  • Average True Range (ATR)
  • AAOI 1.37
  • ALXO 0.12
  • MACD
  • AAOI 0.27
  • ALXO 0.03
  • Stochastic Oscillator
  • AAOI 92.42
  • ALXO 15.79

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products for the Internet data center, cable television, telecommunications and fiber-to-the-home end markets. The company focuses on designing and manufacturing a range of optical communication products from components, to subassemblies, and modules to complete turn-key equipment. Demand for Applied Optoelectronics is driven by bandwidth demand in end markets. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The company derives maximum revenue from Taiwan.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: